Search results for "Clinical Practice"

showing 10 items of 401 documents

Validity of the Mini-Nutritional Assessment Scale for Evaluating Frailty Status in Older Adults

2019

Objectives: Comprehensive Geriatric Assessment (CGA) may not be performed in clinical practice as it takes too much time and requires special training. The Mini-Nutritional Assessment (MNA) is widely used to assess nutritional status in older adults. We aimed to determine whether or not the MNA can estimate frailty status defined by the Fried criteria. Setting and Participants: Six hundred two outpatients aged 65 years or older who underwent the CGA were included the study. Measures: Frailty status was defined by 5 dimensions including shrinking, exhaustion, low levels of activity, weakness, and slowness: 0 for robust, 1–2 for prefrail, and 3–5 for frail. MNA was performed in all participan…

MaleGerontologyMini nutritional assessmentWeaknessIntraclass correlationFrail Elderlymini-nutritional assessmentNutritional StatusSoysal P. ISIK A. ARIK F. KALAN U. EYVAZ A. VERONESE N. -Validity of the Mini-Nutritional Assessment Scale for Evaluating Frailty Status in Older Adults.- Journal of the American Medical Directors Association cilt.20 ss.183-187 201903 medical and health sciences0302 clinical medicineHumansMass ScreeningMedicine030212 general & internal medicineGeriatric AssessmentGeneral NursingAgedAged 80 and overFrailtyReceiver operating characteristicbusiness.industryscreeningHealth PolicyReproducibility of ResultsGeriatric assessmentMean ageGeneral MedicineHealth SurveysClinical PracticeNutrition AssessmentnutritionScale (social sciences)FemaleprefrailtyGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgeryJournal of the American Medical Directors Association
researchProduct

From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickeringʼs legacy

2010

Thomas G. Pickering spent most of his scientific career in carrying out research on clinical hypertension and blood pressure (BP) measurement. In our review of Pickering's seminal work, we first focused on white-coat hypertension and masked hypertension, two terms that he had introduced. Next, we highlighted the early publications of Pickering on diurnal BP variability and on the clinical application of self-measured BP. Pickering's work inspired many investigators worldwide and constituted a solid basis for further research. Pickering's original ideas led to algorithms for risk stratification involving white-coat hypertension and masked hypertension, diurnal BP variability, and self-measur…

MaleGerontologymedicine.medical_specialtyAmbulatory blood pressureAdolescentScientific careerConditioning ClassicalCardiologyWhite coat hypertension030204 cardiovascular system & hematologyAssessment and DiagnosisHistory 21st Century03 medical and health sciences0302 clinical medicineself-measured blood pressureInternal MedicinemedicineHumansBlood pressure monitoringmasked hypertension030212 general & internal medicineChildIntensive care medicineAdvanced and Specialized Nursingbusiness.industryblood pressureGeneral MedicineBlood Pressure Monitoring AmbulatoryHistory 20th Centurymedicine.diseaseCircadian RhythmClinical PracticeMasked HypertensionBlood pressureCardiovascular DiseasesHypertensionRisk stratificationFemaleCardiology and Cardiovascular Medicinebusinessdiurnal blood pressure variabilitywhite-coat hypertensionBlood Pressure Monitoring
researchProduct

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2013

MaleOncologyOrganoplatinum CompoundsOxaloacetatesColorectal cancerLeucovorinColonoscopyChromosome DisordersDeoxycytidineRisk FactorsAntineoplastic Combined Chemotherapy ProtocolsIntestinal MucosaSigmoidoscopyEarly Detection of Cancermedicine.diagnostic_testFollow up studiesColonoscopyHematologyEuropeClinical PracticeTreatment OutcomeOncologyDiagnosis treatmentChemotherapy AdjuvantLymphatic MetastasisOccult BloodColonic NeoplasmsFemaleFluorouracilChromosome Deletionmedicine.drugRiskmedicine.medical_specialtyAntineoplastic AgentsRisk AssessmentCapecitabineInternal medicinemedicineHumansCapecitabineNeoplasm Stagingbusiness.industryGeneral surgeryCancerSigmoidoscopymedicine.diseaseCarcinoembryonic AntigenNeoplasm Recurrence LocalChromosomes Human Pair 18businessFollow-Up StudiesAnnals of Oncology
researchProduct

Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma

2015

Background & aims To develop an individual prognostic calculator for patients with unresectable hepatocellular carcinoma (HCC) undergoing trans-arterial chemo-embolization (TACE). Methods Data from two prospective databases, regarding 361 patients who received TACE as first-line therapy (2000-2012), were reviewed in order to refine available prognostic tools and to develop a continuous individual web-based prognostic calculator. Patients with neoplastic portal vein invasion were excluded from the analysis. The model was built following a bootstrap resampling procedure aimed at identifying prognostic predictors and by carrying out a 10-fold cross-validation for accuracy assessment by means o…

MaleOncologymedicine.medical_specialtyCarcinoma HepatocellularSurvivalHepatocellular carcinomaPrognosimedicine.medical_treatmentPortal veinEmbolization03 medical and health sciences0302 clinical medicineText miningSerum total bilirubinInternal medicineBiomarkers TumorHumansMedicineProspective StudiesEmbolizationChemoembolization TherapeuticAgedHepatologyPortal Veinbusiness.industryLiver NeoplasmsBilirubinMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurgeryClinical PracticeItaly030220 oncology & carcinogenesisHepatocellular carcinomaMultivariate AnalysisCohortTrans-arterial chemo-embolizationPrognostic modelFemale030211 gastroenterology & hepatologybusinessLiver International
researchProduct

Carpal tunnel release surgery: small-area variation and impact of ambulatory surgery in the autonomous region of Valencia, Spain

2013

Objective: This study aimed to analyze variability in rates of carpal tunnel release surgery among the healthcare areas of the autonomous region of Valencia, and to evaluate the contribution of ambulatory surgery and referrals to private hospitals to the variability found. Methods: We carried out a cross-sectional, population-based study, describing the rates of carpal tunnel release surgery, standardized by age and sex, among areas in the region of Valencia in 2006. The observed variation was then analyzed using small-area analysis methods. Data from hospital admissions, referrals to private hospitals, population statistics and hospital resources were used to construct standardized rates, …

MaleOperating Roomsmedicine.medical_specialtyOutpatient Clinics HospitalCross-sectional studySíndrome del túnel carpiano/cirugíaPopulationHospitals PrivateCarpal tunnel syndrome/surgerymedicineColaboración público-privadaHumansOutpatient cliniceducationReferral and ConsultationSmall-Area AnalysisSmall-area variation analysisBed Occupancyeducation.field_of_studyHospitals Publicbusiness.industryPublic Health Environmental and Occupational HealthLength of StayDecompression SurgicalAnálisis de áreas pequeñasCarpal Tunnel SyndromeSurgeryCross-Sectional StudiesOrthopedicsAmbulatory Surgical ProceduresSpainSmall-Area AnalysisPublic hospitalAmbulatoryOrthopedic surgeryClinical practice variationWorkforceFemalePublic-private partnershipsStandardized rateVariabilidad en la práctica médicabusinessGaceta Sanitaria
researchProduct

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

2017

The natural history and its modulation by treatments administered for immune thrombocytopenia (ITP) in the clinical practice remains unknown. In addition, little information is available on the characteristics and management of ITP in Spain. We conducted an observational, multicenter, registry in 70 Hematology Services from Spain between 2009 and 2011, which included children from 2 months of age and adults with primary ITP or another ITP diagnosed within the last 6 months (platelet count [PC]  484 patients were included (median [Q1, Q3] age 52 [29,74] years, 87.6% adults), 56% women, 10.5% with secondary ITP. Median (Q1, Q3) PC at diagnosis was 12 × 109/l (4, 32); 72% of patients had bleed…

MalePediatricsRegistry studyComorbidity030204 cardiovascular system & hematologycorticosteroids0302 clinical medicineAdrenal Cortex Hormonesimmune system diseaseshemic and lymphatic diseasesRegistriesChildresponseHematologyDisease ManagementImmunoglobulins IntravenousHematologyMiddle AgedClinical PracticeNatural historyPhenotypeTreatment OutcomeIntravenous ImmunoglobulinsChild PreschoolFemaleAlgorithmsAdultmedicine.medical_specialtyAdolescentHemorrhageintravenous immunoglobulinsYoung Adult03 medical and health sciencesImmune systemInternal medicinemedicineHumansAgedPurpura Thrombocytopenic IdiopathicPlatelet Countbusiness.industryInfantImmune thrombocytopeniaImmune thrombocytopeniaSpainObservational studybusinessBiomarkers030215 immunologyHematology
researchProduct

Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic…

2021

Background Recent guidelines suggested a wider use of long-acting injectable antipsychotics (LAI) than previously, but naturalistic data on the consequences of LAI use in terms of discontinuation rates and associated factors are still sparse, making it hard for clinicians to be informed on plausible treatment courses. Objective Our objective was to assess, under real-world clinical circumstances, LAI discontinuation rates over a period of 12 months after a first prescription, reasons for discontinuation, and associated factors. Methods The STAR Network ‘Depot Study’ was a naturalistic, multicentre, observational prospective study that enrolled subjects initiating a LAI without restrictions …

MalePediatricsrespectively)0302 clinical medicineDelayed-Action PreparationBrief Psychiatric Rating ScalePharmacology (medical)he STAR Network ‘Depot Study’ prospectively followed 394 subjects initiating treatment with long-acting injections (LAIs) of antipsychotics under naturalistic conditions for 12 months. LAI discontinuation was frequent in everyday clinical practice in ItalyOriginal Research ArticleProspective StudiesProspective cohort studytreatmentMental DisordersHazard ratiowhereas more than half of participants initiating risperidone LAI and olanzapine LAI discontinued during the 12 months of follow-up (51.4 and 62.5%Psychiatric Status Rating ScaleMiddle Agedside efectsPsychiatry and Mental healthItalyMental DisorderFemalehe STAR Network ‘Depot Study’ prospectively followed 394 subjects initiating treatment with long-acting injections (LAIs) of antipsychotics under naturalistic conditions for 12 months. LAI discontinuation was frequent in everyday clinical practice in Italy occurring in almost 40% of the entire sample; side efects participant refusal to continue LAIs and LAIs no longer being required were the most frequently reported reasons for discontinuation. Paliperidone LAI and aripiprazole LAI were the least discontinued medications (33.9 and 35.4% respectively) whereas more than half of participants initiating risperidone LAI and olanzapine LAI discontinued during the 12 months of follow-up (51.4 and 62.5% respectively). In multivariate analysis being prescribed olanzapine LAI and poor medication adherence at baseline were signifcantly associated with higher discontinuation risk.HumanAntipsychotic Agentsmedicine.drugPsychopathologyAdultmedicine.medical_specialtyDiscontinuationFollow-Up StudieMedication Adherence03 medical and health sciencesmedicineHumansPaliperidoneAdverse effectSettore MED/25 - Psichiatriadiscontinuation ratesPsychiatric Status Rating Scalesrespectively). In multivariate analysisbusiness.industryLong-Acting Antipsychoticlong-acting injectable antipsychoticsSurvival AnalysisConfidence intervalparticipant refusal to continue LAIs and LAIs no longer being required were the most frequently reported reasons for discontinuation. Paliperidone LAI and aripiprazole LAI were the least discontinued medications (33.9 and 35.4%030227 psychiatryDiscontinuationProspective StudieAntipsychotic Agentoccurring in almost 40% of the entire sampleDelayed-Action PreparationsNeurology (clinical)business030217 neurology & neurosurgerybeing prescribed olanzapine LAI and poor medication adherence at baseline were signifcantly associated with higher discontinuation riskFollow-Up Studies
researchProduct

IPOD Study: Management of Acute Left Colonic Diverticulitis in Italian Surgical Departments.

2017

Background: In recent years, the emergency management of acute left colonic diverticulitis (ALCD) has evolved dramatically despite lack of strong evidence. As a consequence, management strategies are frequently guided by surgeon’s personal preference, rather than by scientific evidence. The primary aim of IPOD study (Italian Prospective Observational Diverticulitis study) is to describe both the diagnostic and treatment profiles of patients with ALCD in the Italian surgical departments. Methods: IPOD study is a prospective observational study performed during a 6-month period (from April 1 2015 to September 1 2015) and including 89 Italian surgical departments. All consecutive patients with…

MalePercutaneousmedicine.medical_treatmentPractice Patterns030230 surgerySurgery DepartmentDiverticulitis Colonic0302 clinical medicineInterquartile rangeMedicineDiseaseProspective StudiesPractice Patterns Physicians'Prospective cohort studyColectomyColectomyPeritoniticlinical trialDiverticulitisMiddle Agedclinical practiceAnti-Bacterial AgentsItalyCardiothoracic surgery030220 oncology & carcinogenesisDrainageFemaleDiverticulitis; Disease; Colonic diverticulosisHumanColonic diverticulosismedicine.medical_specialtyAged; Anti-Bacterial Agents; Diverticulitis Colonic; Drainage; Female; Humans; Italy; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Surgery Department Hospital; Colectomy; Practice Patterns Physicians'Settore MED/12 - GASTROENTEROLOGIAPeritonitisNO03 medical and health sciencesHospitalColonicAnti-Bacterial AgentHumansDiverticulitisAgedPhysicians'surgery; clinical practice; clinical trialbusiness.industryVascular surgeryLength of Staymedicine.diseaseSurgeryProspective StudieSurgerybusinessSurgery Department HospitalAbdominal surgery
researchProduct

Interest in meta-research in geriatric medicine: a survey of members of the European Geriatric Medicine Society

2020

To know the knowledge of the EuGMS members regarding meta-research, especially systematic reviews and meta-analyses. Interest in systematic reviews and meta-analyses is high and there is a demand for education on these topics in relation to geriatric medicine. We need more resources in the EuGMS for education for meta-research tailored for geriatric medicine. There has been an exponential increase in meta-research, especially in the branch dealing with systematic reviews [SRs] and meta-analyses [MAs]. However, the knowledge regarding these topics in geriatric medicine is still poorly explored. We therefore undertook a survey of the current knowledge and needs in meta-research in geriatrics.…

MaleResearch Reportmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)EuGMSSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)meta-research03 medical and health sciences0302 clinical medicineMeta researchGermanySurveys and QuestionnairesMedicine and Health SciencesmedicineMeta-analysis Systematic review Questionnaire EuGMSHumanssurvey030212 general & internal medicineAgedGeriatricsa survey of members of the European Geriatric Medicine Society- EUROPEAN GERIATRIC MEDICINE 2020 [Veronese N. Torbahn G. Demurtas J. Beaudart C. SOYSAL P. Marengoni A. Shenkin S. D. Petrovic M. Sieber C. C. Cherubini A. et al. -Interest in meta-research in geriatric medicine]030214 geriatricsgeriatric medicinebusiness.industryQuestionnaireEuropean Geriatric Medicine SocietyMiddle AgedClinical PracticeMeta-analysisSystematic reviewGeriatricsFamily medicineMeta-analysisEuGMS; Meta-analysis; Questionnaire; Systematic reviewSystematic reviewEuGMS; Meta-analysis; Questionnaire; Systematic review; Aged; Female; Germany; Humans; Male; Middle Aged; Research Report; Societies; Surveys and Questionnaires; GeriatricsFemalebusinessSocieties
researchProduct

Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy

2017

Homozygous familial hypercholesterolaemia (HoFH) is a rare form of inherited dyslipidemia resistant to conventional cholesterol-lowering medications so that lipoprotein apheresis (LA) is usually required. Lomitapide has been approved for the treatment of HoFH. The aim of this study was to evaluate the benefits of lomitapide in HoFH patients followed with the usual clinical care. Homozygous familial hypercholesterolaemia (HoFH) is a rare form of inherited dyslipidemia resistant to conventional cholesterol-lowering medications so that lipoprotein apheresis (LA) is usually required. Lomitapide has been approved for the treatment of HoFH. The aim of this study was to evaluate the benefits of lo…

MaleSettore MED/09 - Medicina InternaHyperlipidemia Familial Combined030204 cardiovascular system & hematologyPharmacologyBenzimidazolecholesterol-lowering effect; clinical practice; genetics; lomitapide; severe hypercholesterolemia; medicine (all); pharmacology (medical)cholesterol-lowering effectchemistry.chemical_compound0302 clinical medicineRetrospective StudieAnticholesteremic Agentgenetics030212 general & internal medicineAged 80 and overAnticholesteremic AgentsHomozygoteGeneral MedicineMiddle Agedclinical practiceSafety profileItalylipids (amino acids peptides and proteins)FemaleHumanAdultmedicine.medical_specialtySocio-culturaleLiver ultrasoundLDLRAP1 geneHyperlipoproteinemia Type II03 medical and health sciencesGeneticInternal medicinemedicineHumansLiver damagemedicine (all)Familial homozygous hypercholesterolemiaAgedRetrospective Studieslomitapidebusiness.industrysevere hypercholesterolemiamedicine.diseaseRheumatologyLomitapidepharmacology (medical)chemistryBenzimidazolesbusinessDyslipidemia
researchProduct